Lisinopril and Hydrochlorothiazide
- Product NDC
- 68071-4678
- 11-digit product format
- 680714678
- Labeler code
- 68071
- Product ID
- 68071-4678_bb8ba371-f580-1088-e053-2a95a90a4cbf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA076194
- Marketing category
- ANDA
- Marketing start
- 2003-03-04
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL; HYDROCHLOROTHIAZIDE
- Active strength
- 20 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-4678-1 | 68071467801 | 100 TABLET in 1 BOTTLE (68071-4678-1) | 100 tablet | 2018-12-24 | 0000-00-00 | No | No | Current |